nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2C8—Paclitaxel—ovarian cancer	0.0317	0.249	CbGbCtD
Zopiclone—CYP3A4—Topotecan—ovarian cancer	0.0259	0.204	CbGbCtD
Zopiclone—CYP2C9—Paclitaxel—ovarian cancer	0.0221	0.174	CbGbCtD
Zopiclone—CYP3A4—Vinorelbine—ovarian cancer	0.0183	0.144	CbGbCtD
Zopiclone—TSPO—oviduct—ovarian cancer	0.0131	0.123	CbGeAlD
Zopiclone—CYP3A4—Paclitaxel—ovarian cancer	0.0128	0.101	CbGbCtD
Zopiclone—CYP3A4—Docetaxel—ovarian cancer	0.00928	0.0731	CbGbCtD
Zopiclone—PTGS1—oviduct—ovarian cancer	0.00731	0.0686	CbGeAlD
Zopiclone—CYP3A4—Doxorubicin—ovarian cancer	0.00692	0.0545	CbGbCtD
Zopiclone—TSPO—myometrium—ovarian cancer	0.0042	0.0395	CbGeAlD
Zopiclone—TSPO—embryo—ovarian cancer	0.00404	0.0379	CbGeAlD
Zopiclone—GABRG3—testis—ovarian cancer	0.00401	0.0376	CbGeAlD
Zopiclone—TSPO—epithelium—ovarian cancer	0.0033	0.031	CbGeAlD
Zopiclone—TSPO—uterine cervix—ovarian cancer	0.00327	0.0307	CbGeAlD
Zopiclone—TSPO—decidua—ovarian cancer	0.00312	0.0293	CbGeAlD
Zopiclone—GABRA5—testis—ovarian cancer	0.00308	0.0289	CbGeAlD
Zopiclone—TSPO—endometrium—ovarian cancer	0.00296	0.0278	CbGeAlD
Zopiclone—GABRA3—testis—ovarian cancer	0.00287	0.0269	CbGeAlD
Zopiclone—TSPO—gonad—ovarian cancer	0.00274	0.0258	CbGeAlD
Zopiclone—TSPO—uterus—ovarian cancer	0.00273	0.0256	CbGeAlD
Zopiclone—GABRB3—gonad—ovarian cancer	0.00249	0.0234	CbGeAlD
Zopiclone—TSPO—female reproductive system—ovarian cancer	0.00245	0.023	CbGeAlD
Zopiclone—GABRA2—vagina—ovarian cancer	0.00239	0.0225	CbGeAlD
Zopiclone—GABRB2—testis—ovarian cancer	0.00234	0.0219	CbGeAlD
Zopiclone—TSPO—bone marrow—ovarian cancer	0.00231	0.0217	CbGeAlD
Zopiclone—TSPO—female gonad—ovarian cancer	0.00223	0.0209	CbGeAlD
Zopiclone—GABRB3—female reproductive system—ovarian cancer	0.00223	0.0209	CbGeAlD
Zopiclone—TSPO—vagina—ovarian cancer	0.00222	0.0208	CbGeAlD
Zopiclone—CYP2C8—endometrium—ovarian cancer	0.00203	0.0191	CbGeAlD
Zopiclone—TSPO—testis—ovarian cancer	0.00198	0.0186	CbGeAlD
Zopiclone—PTGS1—epithelium—ovarian cancer	0.00184	0.0172	CbGeAlD
Zopiclone—PTGS1—uterine cervix—ovarian cancer	0.00182	0.0171	CbGeAlD
Zopiclone—GABRB3—testis—ovarian cancer	0.0018	0.0169	CbGeAlD
Zopiclone—CYP2C8—female reproductive system—ovarian cancer	0.00168	0.0158	CbGeAlD
Zopiclone—PTGS1—endometrium—ovarian cancer	0.00165	0.0155	CbGeAlD
Zopiclone—GABRA2—lymph node—ovarian cancer	0.00155	0.0145	CbGeAlD
Zopiclone—CYP2C8—vagina—ovarian cancer	0.00152	0.0143	CbGeAlD
Zopiclone—PTGS1—uterus—ovarian cancer	0.00152	0.0142	CbGeAlD
Zopiclone—CYP2C9—female reproductive system—ovarian cancer	0.00149	0.014	CbGeAlD
Zopiclone—TSPO—lymph node—ovarian cancer	0.00143	0.0135	CbGeAlD
Zopiclone—CYP2E1—female reproductive system—ovarian cancer	0.00142	0.0133	CbGeAlD
Zopiclone—PTGS1—female reproductive system—ovarian cancer	0.00136	0.0128	CbGeAlD
Zopiclone—CYP2C8—testis—ovarian cancer	0.00136	0.0127	CbGeAlD
Zopiclone—PTGS1—female gonad—ovarian cancer	0.00124	0.0116	CbGeAlD
Zopiclone—PTGS1—vagina—ovarian cancer	0.00123	0.0116	CbGeAlD
Zopiclone—CYP2E1—testis—ovarian cancer	0.00114	0.0107	CbGeAlD
Zopiclone—CYP3A4—female reproductive system—ovarian cancer	0.00114	0.0107	CbGeAlD
Zopiclone—PTGS1—testis—ovarian cancer	0.0011	0.0103	CbGeAlD
Zopiclone—PTGS1—lymph node—ovarian cancer	0.000798	0.00749	CbGeAlD
Zopiclone—Myalgia—Paclitaxel—ovarian cancer	0.000633	0.000843	CcSEcCtD
Zopiclone—Anxiety—Paclitaxel—ovarian cancer	0.000631	0.00084	CcSEcCtD
Zopiclone—Face oedema—Doxorubicin—ovarian cancer	0.00063	0.00084	CcSEcCtD
Zopiclone—Nausea—Topotecan—ovarian cancer	0.000626	0.000835	CcSEcCtD
Zopiclone—Discomfort—Paclitaxel—ovarian cancer	0.000625	0.000833	CcSEcCtD
Zopiclone—Gastritis—Epirubicin—ovarian cancer	0.000624	0.000832	CcSEcCtD
Zopiclone—Muscular weakness—Epirubicin—ovarian cancer	0.000622	0.000829	CcSEcCtD
Zopiclone—Dry mouth—Paclitaxel—ovarian cancer	0.000619	0.000825	CcSEcCtD
Zopiclone—Mood swings—Doxorubicin—ovarian cancer	0.000619	0.000824	CcSEcCtD
Zopiclone—Diarrhoea—Vinorelbine—ovarian cancer	0.000617	0.000822	CcSEcCtD
Zopiclone—Dysgeusia—Docetaxel—ovarian cancer	0.000617	0.000822	CcSEcCtD
Zopiclone—Ataxia—Doxorubicin—ovarian cancer	0.000614	0.000818	CcSEcCtD
Zopiclone—Nausea—Melphalan—ovarian cancer	0.000613	0.000817	CcSEcCtD
Zopiclone—Confusional state—Paclitaxel—ovarian cancer	0.000612	0.000815	CcSEcCtD
Zopiclone—Influenza—Epirubicin—ovarian cancer	0.00061	0.000813	CcSEcCtD
Zopiclone—Asthma—Epirubicin—ovarian cancer	0.00061	0.000813	CcSEcCtD
Zopiclone—Dysphagia—Epirubicin—ovarian cancer	0.00061	0.000813	CcSEcCtD
Zopiclone—Back pain—Docetaxel—ovarian cancer	0.000609	0.000812	CcSEcCtD
Zopiclone—Dehydration—Doxorubicin—ovarian cancer	0.000607	0.000809	CcSEcCtD
Zopiclone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000607	0.000808	CcSEcCtD
Zopiclone—Muscle spasms—Docetaxel—ovarian cancer	0.000606	0.000807	CcSEcCtD
Zopiclone—Infection—Paclitaxel—ovarian cancer	0.000603	0.000803	CcSEcCtD
Zopiclone—Dry skin—Doxorubicin—ovarian cancer	0.000598	0.000798	CcSEcCtD
Zopiclone—Dizziness—Vinorelbine—ovarian cancer	0.000596	0.000795	CcSEcCtD
Zopiclone—Hypokalaemia—Doxorubicin—ovarian cancer	0.000594	0.000792	CcSEcCtD
Zopiclone—Tachycardia—Paclitaxel—ovarian cancer	0.000592	0.000789	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000588	0.000783	CcSEcCtD
Zopiclone—Bronchitis—Epirubicin—ovarian cancer	0.000587	0.000782	CcSEcCtD
Zopiclone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000586	0.000781	CcSEcCtD
Zopiclone—Anaemia—Docetaxel—ovarian cancer	0.000582	0.000776	CcSEcCtD
Zopiclone—Anorexia—Paclitaxel—ovarian cancer	0.000578	0.000771	CcSEcCtD
Zopiclone—Gastritis—Doxorubicin—ovarian cancer	0.000578	0.00077	CcSEcCtD
Zopiclone—Muscular weakness—Doxorubicin—ovarian cancer	0.000576	0.000767	CcSEcCtD
Zopiclone—Vomiting—Vinorelbine—ovarian cancer	0.000573	0.000764	CcSEcCtD
Zopiclone—Dysuria—Epirubicin—ovarian cancer	0.00057	0.00076	CcSEcCtD
Zopiclone—Rash—Vinorelbine—ovarian cancer	0.000569	0.000758	CcSEcCtD
Zopiclone—Dermatitis—Vinorelbine—ovarian cancer	0.000568	0.000757	CcSEcCtD
Zopiclone—Headache—Vinorelbine—ovarian cancer	0.000565	0.000753	CcSEcCtD
Zopiclone—Dysphagia—Doxorubicin—ovarian cancer	0.000564	0.000752	CcSEcCtD
Zopiclone—Influenza—Doxorubicin—ovarian cancer	0.000564	0.000752	CcSEcCtD
Zopiclone—Asthma—Doxorubicin—ovarian cancer	0.000564	0.000752	CcSEcCtD
Zopiclone—Pollakiuria—Epirubicin—ovarian cancer	0.000563	0.000751	CcSEcCtD
Zopiclone—Palpitations—Docetaxel—ovarian cancer	0.000557	0.000742	CcSEcCtD
Zopiclone—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000557	0.000742	CcSEcCtD
Zopiclone—Weight increased—Epirubicin—ovarian cancer	0.000555	0.00074	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000553	0.000737	CcSEcCtD
Zopiclone—Weight decreased—Epirubicin—ovarian cancer	0.000552	0.000735	CcSEcCtD
Zopiclone—Insomnia—Paclitaxel—ovarian cancer	0.000549	0.000731	CcSEcCtD
Zopiclone—Convulsion—Docetaxel—ovarian cancer	0.000546	0.000727	CcSEcCtD
Zopiclone—Paraesthesia—Paclitaxel—ovarian cancer	0.000545	0.000726	CcSEcCtD
Zopiclone—Hypertension—Docetaxel—ovarian cancer	0.000544	0.000725	CcSEcCtD
Zopiclone—Drowsiness—Epirubicin—ovarian cancer	0.000544	0.000725	CcSEcCtD
Zopiclone—Bronchitis—Doxorubicin—ovarian cancer	0.000543	0.000723	CcSEcCtD
Zopiclone—Dyspnoea—Paclitaxel—ovarian cancer	0.000541	0.000721	CcSEcCtD
Zopiclone—Somnolence—Paclitaxel—ovarian cancer	0.000539	0.000719	CcSEcCtD
Zopiclone—Chest pain—Docetaxel—ovarian cancer	0.000536	0.000715	CcSEcCtD
Zopiclone—Myalgia—Docetaxel—ovarian cancer	0.000536	0.000715	CcSEcCtD
Zopiclone—Nausea—Vinorelbine—ovarian cancer	0.000536	0.000714	CcSEcCtD
Zopiclone—Dyspepsia—Paclitaxel—ovarian cancer	0.000534	0.000712	CcSEcCtD
Zopiclone—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000533	0.00071	CcSEcCtD
Zopiclone—Stomatitis—Epirubicin—ovarian cancer	0.00053	0.000706	CcSEcCtD
Zopiclone—Conjunctivitis—Epirubicin—ovarian cancer	0.000529	0.000704	CcSEcCtD
Zopiclone—Urinary tract infection—Epirubicin—ovarian cancer	0.000529	0.000704	CcSEcCtD
Zopiclone—Dysuria—Doxorubicin—ovarian cancer	0.000528	0.000703	CcSEcCtD
Zopiclone—Decreased appetite—Paclitaxel—ovarian cancer	0.000527	0.000703	CcSEcCtD
Zopiclone—Dry mouth—Docetaxel—ovarian cancer	0.000525	0.000699	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000524	0.000698	CcSEcCtD
Zopiclone—Fatigue—Paclitaxel—ovarian cancer	0.000523	0.000697	CcSEcCtD
Zopiclone—Sweating—Epirubicin—ovarian cancer	0.000521	0.000695	CcSEcCtD
Zopiclone—Pollakiuria—Doxorubicin—ovarian cancer	0.000521	0.000695	CcSEcCtD
Zopiclone—Constipation—Paclitaxel—ovarian cancer	0.000519	0.000691	CcSEcCtD
Zopiclone—Pain—Paclitaxel—ovarian cancer	0.000519	0.000691	CcSEcCtD
Zopiclone—Haematuria—Epirubicin—ovarian cancer	0.000518	0.000691	CcSEcCtD
Zopiclone—Confusional state—Docetaxel—ovarian cancer	0.000518	0.000691	CcSEcCtD
Zopiclone—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000515	0.000686	CcSEcCtD
Zopiclone—Anaphylactic shock—Docetaxel—ovarian cancer	0.000514	0.000685	CcSEcCtD
Zopiclone—Weight increased—Doxorubicin—ovarian cancer	0.000514	0.000684	CcSEcCtD
Zopiclone—Epistaxis—Epirubicin—ovarian cancer	0.000513	0.000683	CcSEcCtD
Zopiclone—Infection—Docetaxel—ovarian cancer	0.000511	0.000681	CcSEcCtD
Zopiclone—Weight decreased—Doxorubicin—ovarian cancer	0.000511	0.00068	CcSEcCtD
Zopiclone—Drowsiness—Doxorubicin—ovarian cancer	0.000503	0.00067	CcSEcCtD
Zopiclone—Tachycardia—Docetaxel—ovarian cancer	0.000502	0.000669	CcSEcCtD
Zopiclone—Feeling abnormal—Paclitaxel—ovarian cancer	0.0005	0.000666	CcSEcCtD
Zopiclone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000496	0.000661	CcSEcCtD
Zopiclone—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000493	0.000657	CcSEcCtD
Zopiclone—Stomatitis—Doxorubicin—ovarian cancer	0.00049	0.000654	CcSEcCtD
Zopiclone—Anorexia—Docetaxel—ovarian cancer	0.00049	0.000653	CcSEcCtD
Zopiclone—Rhinitis—Epirubicin—ovarian cancer	0.000489	0.000652	CcSEcCtD
Zopiclone—Conjunctivitis—Doxorubicin—ovarian cancer	0.000489	0.000652	CcSEcCtD
Zopiclone—Urinary tract infection—Doxorubicin—ovarian cancer	0.000489	0.000652	CcSEcCtD
Zopiclone—Hepatitis—Epirubicin—ovarian cancer	0.000488	0.000651	CcSEcCtD
Zopiclone—Hypoaesthesia—Epirubicin—ovarian cancer	0.000486	0.000647	CcSEcCtD
Zopiclone—Pharyngitis—Epirubicin—ovarian cancer	0.000485	0.000646	CcSEcCtD
Zopiclone—Sweating—Doxorubicin—ovarian cancer	0.000482	0.000643	CcSEcCtD
Zopiclone—Urticaria—Paclitaxel—ovarian cancer	0.000482	0.000642	CcSEcCtD
Zopiclone—Oedema peripheral—Epirubicin—ovarian cancer	0.000481	0.000641	CcSEcCtD
Zopiclone—Haematuria—Doxorubicin—ovarian cancer	0.00048	0.000639	CcSEcCtD
Zopiclone—Abdominal pain—Paclitaxel—ovarian cancer	0.00048	0.000639	CcSEcCtD
Zopiclone—Body temperature increased—Paclitaxel—ovarian cancer	0.00048	0.000639	CcSEcCtD
Zopiclone—Epistaxis—Doxorubicin—ovarian cancer	0.000475	0.000632	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000468	0.000624	CcSEcCtD
Zopiclone—Insomnia—Docetaxel—ovarian cancer	0.000465	0.00062	CcSEcCtD
Zopiclone—Paraesthesia—Docetaxel—ovarian cancer	0.000462	0.000615	CcSEcCtD
Zopiclone—Erythema multiforme—Epirubicin—ovarian cancer	0.000462	0.000615	CcSEcCtD
Zopiclone—Dyspnoea—Docetaxel—ovarian cancer	0.000458	0.000611	CcSEcCtD
Zopiclone—Somnolence—Docetaxel—ovarian cancer	0.000457	0.000609	CcSEcCtD
Zopiclone—Tinnitus—Epirubicin—ovarian cancer	0.000455	0.000607	CcSEcCtD
Zopiclone—Rhinitis—Doxorubicin—ovarian cancer	0.000453	0.000603	CcSEcCtD
Zopiclone—Dyspepsia—Docetaxel—ovarian cancer	0.000453	0.000603	CcSEcCtD
Zopiclone—Hepatitis—Doxorubicin—ovarian cancer	0.000452	0.000602	CcSEcCtD
Zopiclone—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000449	0.000599	CcSEcCtD
Zopiclone—Pharyngitis—Doxorubicin—ovarian cancer	0.000448	0.000597	CcSEcCtD
Zopiclone—Decreased appetite—Docetaxel—ovarian cancer	0.000447	0.000596	CcSEcCtD
Zopiclone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000447	0.000596	CcSEcCtD
Zopiclone—Oedema peripheral—Doxorubicin—ovarian cancer	0.000445	0.000593	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000444	0.000592	CcSEcCtD
Zopiclone—Fatigue—Docetaxel—ovarian cancer	0.000443	0.000591	CcSEcCtD
Zopiclone—Constipation—Docetaxel—ovarian cancer	0.00044	0.000586	CcSEcCtD
Zopiclone—Pain—Docetaxel—ovarian cancer	0.00044	0.000586	CcSEcCtD
Zopiclone—Chills—Epirubicin—ovarian cancer	0.000438	0.000584	CcSEcCtD
Zopiclone—Asthenia—Paclitaxel—ovarian cancer	0.000435	0.00058	CcSEcCtD
Zopiclone—Alopecia—Epirubicin—ovarian cancer	0.000431	0.000575	CcSEcCtD
Zopiclone—Pruritus—Paclitaxel—ovarian cancer	0.000429	0.000572	CcSEcCtD
Zopiclone—Erythema multiforme—Doxorubicin—ovarian cancer	0.000427	0.000569	CcSEcCtD
Zopiclone—Feeling abnormal—Docetaxel—ovarian cancer	0.000424	0.000565	CcSEcCtD
Zopiclone—Tinnitus—Doxorubicin—ovarian cancer	0.000421	0.000561	CcSEcCtD
Zopiclone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00042	0.00056	CcSEcCtD
Zopiclone—Tension—Epirubicin—ovarian cancer	0.000417	0.000556	CcSEcCtD
Zopiclone—Dysgeusia—Epirubicin—ovarian cancer	0.000416	0.000555	CcSEcCtD
Zopiclone—Diarrhoea—Paclitaxel—ovarian cancer	0.000415	0.000553	CcSEcCtD
Zopiclone—Nervousness—Epirubicin—ovarian cancer	0.000413	0.00055	CcSEcCtD
Zopiclone—Back pain—Epirubicin—ovarian cancer	0.000411	0.000548	CcSEcCtD
Zopiclone—Muscle spasms—Epirubicin—ovarian cancer	0.000409	0.000544	CcSEcCtD
Zopiclone—Abdominal pain—Docetaxel—ovarian cancer	0.000406	0.000542	CcSEcCtD
Zopiclone—Body temperature increased—Docetaxel—ovarian cancer	0.000406	0.000542	CcSEcCtD
Zopiclone—Chills—Doxorubicin—ovarian cancer	0.000405	0.00054	CcSEcCtD
Zopiclone—Dizziness—Paclitaxel—ovarian cancer	0.000401	0.000535	CcSEcCtD
Zopiclone—Vision blurred—Epirubicin—ovarian cancer	0.0004	0.000534	CcSEcCtD
Zopiclone—Alopecia—Doxorubicin—ovarian cancer	0.000399	0.000532	CcSEcCtD
Zopiclone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000394	0.000525	CcSEcCtD
Zopiclone—Anaemia—Epirubicin—ovarian cancer	0.000393	0.000523	CcSEcCtD
Zopiclone—Agitation—Epirubicin—ovarian cancer	0.000391	0.00052	CcSEcCtD
Zopiclone—Tension—Doxorubicin—ovarian cancer	0.000386	0.000514	CcSEcCtD
Zopiclone—Vomiting—Paclitaxel—ovarian cancer	0.000386	0.000514	CcSEcCtD
Zopiclone—Dysgeusia—Doxorubicin—ovarian cancer	0.000385	0.000513	CcSEcCtD
Zopiclone—Malaise—Epirubicin—ovarian cancer	0.000383	0.000511	CcSEcCtD
Zopiclone—Rash—Paclitaxel—ovarian cancer	0.000382	0.00051	CcSEcCtD
Zopiclone—Dermatitis—Paclitaxel—ovarian cancer	0.000382	0.000509	CcSEcCtD
Zopiclone—Nervousness—Doxorubicin—ovarian cancer	0.000382	0.000509	CcSEcCtD
Zopiclone—Vertigo—Epirubicin—ovarian cancer	0.000382	0.000509	CcSEcCtD
Zopiclone—Back pain—Doxorubicin—ovarian cancer	0.00038	0.000507	CcSEcCtD
Zopiclone—Headache—Paclitaxel—ovarian cancer	0.00038	0.000506	CcSEcCtD
Zopiclone—Hypersensitivity—Docetaxel—ovarian cancer	0.000379	0.000505	CcSEcCtD
Zopiclone—Muscle spasms—Doxorubicin—ovarian cancer	0.000378	0.000504	CcSEcCtD
Zopiclone—Palpitations—Epirubicin—ovarian cancer	0.000376	0.0005	CcSEcCtD
Zopiclone—Vision blurred—Doxorubicin—ovarian cancer	0.000371	0.000494	CcSEcCtD
Zopiclone—Asthenia—Docetaxel—ovarian cancer	0.000369	0.000492	CcSEcCtD
Zopiclone—Convulsion—Epirubicin—ovarian cancer	0.000368	0.000491	CcSEcCtD
Zopiclone—Hypertension—Epirubicin—ovarian cancer	0.000367	0.000489	CcSEcCtD
Zopiclone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000365	0.000486	CcSEcCtD
Zopiclone—Pruritus—Docetaxel—ovarian cancer	0.000364	0.000485	CcSEcCtD
Zopiclone—Anaemia—Doxorubicin—ovarian cancer	0.000363	0.000484	CcSEcCtD
Zopiclone—Chest pain—Epirubicin—ovarian cancer	0.000362	0.000482	CcSEcCtD
Zopiclone—Myalgia—Epirubicin—ovarian cancer	0.000362	0.000482	CcSEcCtD
Zopiclone—Agitation—Doxorubicin—ovarian cancer	0.000361	0.000482	CcSEcCtD
Zopiclone—Anxiety—Epirubicin—ovarian cancer	0.000361	0.00048	CcSEcCtD
Zopiclone—Nausea—Paclitaxel—ovarian cancer	0.00036	0.00048	CcSEcCtD
Zopiclone—Discomfort—Epirubicin—ovarian cancer	0.000357	0.000476	CcSEcCtD
Zopiclone—Malaise—Doxorubicin—ovarian cancer	0.000355	0.000473	CcSEcCtD
Zopiclone—Dry mouth—Epirubicin—ovarian cancer	0.000354	0.000472	CcSEcCtD
Zopiclone—Vertigo—Doxorubicin—ovarian cancer	0.000353	0.000471	CcSEcCtD
Zopiclone—Diarrhoea—Docetaxel—ovarian cancer	0.000352	0.000469	CcSEcCtD
Zopiclone—Confusional state—Epirubicin—ovarian cancer	0.00035	0.000466	CcSEcCtD
Zopiclone—Palpitations—Doxorubicin—ovarian cancer	0.000347	0.000463	CcSEcCtD
Zopiclone—Anaphylactic shock—Epirubicin—ovarian cancer	0.000347	0.000462	CcSEcCtD
Zopiclone—Infection—Epirubicin—ovarian cancer	0.000345	0.000459	CcSEcCtD
Zopiclone—Convulsion—Doxorubicin—ovarian cancer	0.000341	0.000454	CcSEcCtD
Zopiclone—Dizziness—Docetaxel—ovarian cancer	0.00034	0.000453	CcSEcCtD
Zopiclone—Hypertension—Doxorubicin—ovarian cancer	0.000339	0.000452	CcSEcCtD
Zopiclone—Tachycardia—Epirubicin—ovarian cancer	0.000338	0.000451	CcSEcCtD
Zopiclone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000335	0.000447	CcSEcCtD
Zopiclone—Chest pain—Doxorubicin—ovarian cancer	0.000335	0.000446	CcSEcCtD
Zopiclone—Myalgia—Doxorubicin—ovarian cancer	0.000335	0.000446	CcSEcCtD
Zopiclone—Anxiety—Doxorubicin—ovarian cancer	0.000334	0.000445	CcSEcCtD
Zopiclone—Discomfort—Doxorubicin—ovarian cancer	0.000331	0.000441	CcSEcCtD
Zopiclone—Anorexia—Epirubicin—ovarian cancer	0.000331	0.000441	CcSEcCtD
Zopiclone—Dry mouth—Doxorubicin—ovarian cancer	0.000327	0.000436	CcSEcCtD
Zopiclone—Vomiting—Docetaxel—ovarian cancer	0.000327	0.000436	CcSEcCtD
Zopiclone—Rash—Docetaxel—ovarian cancer	0.000324	0.000432	CcSEcCtD
Zopiclone—Dermatitis—Docetaxel—ovarian cancer	0.000324	0.000432	CcSEcCtD
Zopiclone—Confusional state—Doxorubicin—ovarian cancer	0.000324	0.000431	CcSEcCtD
Zopiclone—Headache—Docetaxel—ovarian cancer	0.000322	0.000429	CcSEcCtD
Zopiclone—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000321	0.000428	CcSEcCtD
Zopiclone—Infection—Doxorubicin—ovarian cancer	0.000319	0.000425	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000316	0.000421	CcSEcCtD
Zopiclone—Insomnia—Epirubicin—ovarian cancer	0.000314	0.000418	CcSEcCtD
Zopiclone—Tachycardia—Doxorubicin—ovarian cancer	0.000313	0.000417	CcSEcCtD
Zopiclone—Paraesthesia—Epirubicin—ovarian cancer	0.000311	0.000415	CcSEcCtD
Zopiclone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00031	0.000413	CcSEcCtD
Zopiclone—Dyspnoea—Epirubicin—ovarian cancer	0.000309	0.000412	CcSEcCtD
Zopiclone—Somnolence—Epirubicin—ovarian cancer	0.000308	0.000411	CcSEcCtD
Zopiclone—Anorexia—Doxorubicin—ovarian cancer	0.000306	0.000408	CcSEcCtD
Zopiclone—Nausea—Docetaxel—ovarian cancer	0.000305	0.000407	CcSEcCtD
Zopiclone—Dyspepsia—Epirubicin—ovarian cancer	0.000305	0.000407	CcSEcCtD
Zopiclone—Decreased appetite—Epirubicin—ovarian cancer	0.000301	0.000402	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000299	0.000399	CcSEcCtD
Zopiclone—Fatigue—Epirubicin—ovarian cancer	0.000299	0.000398	CcSEcCtD
Zopiclone—Constipation—Epirubicin—ovarian cancer	0.000297	0.000395	CcSEcCtD
Zopiclone—Pain—Epirubicin—ovarian cancer	0.000297	0.000395	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000292	0.00039	CcSEcCtD
Zopiclone—Insomnia—Doxorubicin—ovarian cancer	0.00029	0.000387	CcSEcCtD
Zopiclone—Paraesthesia—Doxorubicin—ovarian cancer	0.000288	0.000384	CcSEcCtD
Zopiclone—Dyspnoea—Doxorubicin—ovarian cancer	0.000286	0.000381	CcSEcCtD
Zopiclone—Feeling abnormal—Epirubicin—ovarian cancer	0.000286	0.000381	CcSEcCtD
Zopiclone—Somnolence—Doxorubicin—ovarian cancer	0.000285	0.00038	CcSEcCtD
Zopiclone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000284	0.000378	CcSEcCtD
Zopiclone—Dyspepsia—Doxorubicin—ovarian cancer	0.000282	0.000376	CcSEcCtD
Zopiclone—Decreased appetite—Doxorubicin—ovarian cancer	0.000279	0.000372	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000277	0.000369	CcSEcCtD
Zopiclone—Fatigue—Doxorubicin—ovarian cancer	0.000277	0.000369	CcSEcCtD
Zopiclone—Urticaria—Epirubicin—ovarian cancer	0.000276	0.000367	CcSEcCtD
Zopiclone—Constipation—Doxorubicin—ovarian cancer	0.000274	0.000366	CcSEcCtD
Zopiclone—Pain—Doxorubicin—ovarian cancer	0.000274	0.000366	CcSEcCtD
Zopiclone—Body temperature increased—Epirubicin—ovarian cancer	0.000274	0.000365	CcSEcCtD
Zopiclone—Abdominal pain—Epirubicin—ovarian cancer	0.000274	0.000365	CcSEcCtD
Zopiclone—Feeling abnormal—Doxorubicin—ovarian cancer	0.000264	0.000352	CcSEcCtD
Zopiclone—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000262	0.00035	CcSEcCtD
Zopiclone—Hypersensitivity—Epirubicin—ovarian cancer	0.000256	0.000341	CcSEcCtD
Zopiclone—Urticaria—Doxorubicin—ovarian cancer	0.000255	0.00034	CcSEcCtD
Zopiclone—Abdominal pain—Doxorubicin—ovarian cancer	0.000254	0.000338	CcSEcCtD
Zopiclone—Body temperature increased—Doxorubicin—ovarian cancer	0.000254	0.000338	CcSEcCtD
Zopiclone—Asthenia—Epirubicin—ovarian cancer	0.000249	0.000332	CcSEcCtD
Zopiclone—Pruritus—Epirubicin—ovarian cancer	0.000245	0.000327	CcSEcCtD
Zopiclone—Diarrhoea—Epirubicin—ovarian cancer	0.000237	0.000316	CcSEcCtD
Zopiclone—Hypersensitivity—Doxorubicin—ovarian cancer	0.000236	0.000315	CcSEcCtD
Zopiclone—Asthenia—Doxorubicin—ovarian cancer	0.00023	0.000307	CcSEcCtD
Zopiclone—Dizziness—Epirubicin—ovarian cancer	0.000229	0.000306	CcSEcCtD
Zopiclone—Pruritus—Doxorubicin—ovarian cancer	0.000227	0.000303	CcSEcCtD
Zopiclone—Vomiting—Epirubicin—ovarian cancer	0.000221	0.000294	CcSEcCtD
Zopiclone—Diarrhoea—Doxorubicin—ovarian cancer	0.00022	0.000293	CcSEcCtD
Zopiclone—Rash—Epirubicin—ovarian cancer	0.000219	0.000291	CcSEcCtD
Zopiclone—Dermatitis—Epirubicin—ovarian cancer	0.000218	0.000291	CcSEcCtD
Zopiclone—Headache—Epirubicin—ovarian cancer	0.000217	0.00029	CcSEcCtD
Zopiclone—Dizziness—Doxorubicin—ovarian cancer	0.000212	0.000283	CcSEcCtD
Zopiclone—Nausea—Epirubicin—ovarian cancer	0.000206	0.000275	CcSEcCtD
Zopiclone—Vomiting—Doxorubicin—ovarian cancer	0.000204	0.000272	CcSEcCtD
Zopiclone—Rash—Doxorubicin—ovarian cancer	0.000202	0.00027	CcSEcCtD
Zopiclone—Dermatitis—Doxorubicin—ovarian cancer	0.000202	0.000269	CcSEcCtD
Zopiclone—Headache—Doxorubicin—ovarian cancer	0.000201	0.000268	CcSEcCtD
Zopiclone—Nausea—Doxorubicin—ovarian cancer	0.000191	0.000254	CcSEcCtD
Zopiclone—GABRB2—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.47e-05	0.00341	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.31e-05	0.00331	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	5.24e-05	0.00327	CbGpPWpGaD
Zopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	5.22e-05	0.00325	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.21e-05	0.00325	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.12e-05	0.0032	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	5.09e-05	0.00318	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.09e-05	0.00318	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—AQP3—ovarian cancer	5e-05	0.00312	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	5e-05	0.00312	CbGpPWpGaD
Zopiclone—PTGS1—Biological oxidations—CYP1B1—ovarian cancer	4.99e-05	0.00312	CbGpPWpGaD
Zopiclone—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	4.97e-05	0.0031	CbGpPWpGaD
Zopiclone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	4.94e-05	0.00308	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.92e-05	0.00307	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.91e-05	0.00306	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.88e-05	0.00304	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.79e-05	0.00299	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—APC—ovarian cancer	4.47e-05	0.00279	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—AQP3—ovarian cancer	4.37e-05	0.00273	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.19e-05	0.00261	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.14e-05	0.00258	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.02e-05	0.00251	CbGpPWpGaD
Zopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	4.02e-05	0.00251	CbGpPWpGaD
Zopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	3.97e-05	0.00248	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.95e-05	0.00246	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.88e-05	0.00242	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.86e-05	0.00241	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.85e-05	0.0024	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.79e-05	0.00236	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	3.73e-05	0.00233	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	3.68e-05	0.0023	CbGpPWpGaD
Zopiclone—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	3.61e-05	0.00226	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—MTOR—ovarian cancer	3.42e-05	0.00214	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.31e-05	0.00207	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.28e-05	0.00205	CbGpPWpGaD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	3.26e-05	0.00203	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—CYP1B1—ovarian cancer	3.23e-05	0.00201	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP1B1—ovarian cancer	3.18e-05	0.00198	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.17e-05	0.00198	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—CASP3—ovarian cancer	3.15e-05	0.00196	CbGpPWpGaD
Zopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.14e-05	0.00196	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NME2—ovarian cancer	3.04e-05	0.0019	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—CTNNB1—ovarian cancer	3.03e-05	0.00189	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.76e-05	0.00172	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.68e-05	0.00167	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.67e-05	0.00167	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	2.65e-05	0.00165	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—STAT3—ovarian cancer	2.65e-05	0.00165	CbGpPWpGaD
Zopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.64e-05	0.00165	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.64e-05	0.00164	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	2.63e-05	0.00164	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.59e-05	0.00162	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.59e-05	0.00162	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	2.59e-05	0.00162	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.58e-05	0.00161	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.57e-05	0.00161	CbGpPWpGaD
Zopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.57e-05	0.0016	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.55e-05	0.00159	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	2.53e-05	0.00158	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.53e-05	0.00158	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—MAPK3—ovarian cancer	2.53e-05	0.00158	CbGpPWpGaD
Zopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.52e-05	0.00157	CbGpPWpGaD
Zopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.52e-05	0.00157	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.5e-05	0.00156	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.5e-05	0.00156	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.49e-05	0.00155	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.49e-05	0.00155	CbGpPWpGaD
Zopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.48e-05	0.00154	CbGpPWpGaD
Zopiclone—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.46e-05	0.00153	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	2.44e-05	0.00152	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.44e-05	0.00152	CbGpPWpGaD
Zopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.41e-05	0.00151	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	2.4e-05	0.0015	CbGpPWpGaD
Zopiclone—GABRG3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.36e-05	0.00147	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NME2—ovarian cancer	2.28e-05	0.00142	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.21e-05	0.00138	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	2.15e-05	0.00134	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.13e-05	0.00133	CbGpPWpGaD
Zopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.12e-05	0.00132	CbGpPWpGaD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.11e-05	0.00132	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.11e-05	0.00131	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.11e-05	0.00131	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	2.1e-05	0.00131	CbGpPWpGaD
Zopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.06e-05	0.00128	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.05e-05	0.00128	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.02e-05	0.00126	CbGpPWpGaD
Zopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.02e-05	0.00126	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.01e-05	0.00125	CbGpPWpGaD
Zopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	1.99e-05	0.00124	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.98e-05	0.00124	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.98e-05	0.00123	CbGpPWpGaD
Zopiclone—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	1.97e-05	0.00123	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NME2—ovarian cancer	1.97e-05	0.00123	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.96e-05	0.00122	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYTB—ovarian cancer	1.96e-05	0.00122	CbGpPWpGaD
Zopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	1.94e-05	0.00121	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	1.93e-05	0.0012	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.93e-05	0.0012	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.93e-05	0.0012	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.92e-05	0.0012	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.89e-05	0.00118	CbGpPWpGaD
Zopiclone—GABRG3—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.89e-05	0.00118	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.86e-05	0.00116	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.85e-05	0.00115	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.82e-05	0.00113	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—MAPK1—ovarian cancer	1.81e-05	0.00113	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	1.73e-05	0.00108	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—BRIP1—ovarian cancer	1.71e-05	0.00107	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PPP1CC—ovarian cancer	1.71e-05	0.00107	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	1.71e-05	0.00107	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	1.7e-05	0.00106	CbGpPWpGaD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	1.69e-05	0.00106	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.68e-05	0.00105	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.67e-05	0.00104	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NME2—ovarian cancer	1.6e-05	0.000998	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.59e-05	0.000994	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.59e-05	0.00099	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.55e-05	0.000966	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—MAPK1—ovarian cancer	1.52e-05	0.000949	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.52e-05	0.000948	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.49e-05	0.000932	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	1.49e-05	0.000928	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.48e-05	0.000926	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—MAPK1—ovarian cancer	1.48e-05	0.000922	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYTB—ovarian cancer	1.47e-05	0.000915	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.46e-05	0.000909	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—MAPK1—ovarian cancer	1.45e-05	0.000905	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—HRAS—ovarian cancer	1.45e-05	0.000905	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—MAPK1—ovarian cancer	1.43e-05	0.000889	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—MAPK1—ovarian cancer	1.42e-05	0.000884	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—MAPK1—ovarian cancer	1.39e-05	0.000868	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.36e-05	0.000848	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.36e-05	0.000847	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PPP1CC—ovarian cancer	1.28e-05	0.000799	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—BRIP1—ovarian cancer	1.28e-05	0.000799	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.27e-05	0.000795	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYTB—ovarian cancer	1.27e-05	0.000791	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.25e-05	0.00078	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.24e-05	0.000773	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—HRAS—ovarian cancer	1.22e-05	0.000762	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—MAPK1—ovarian cancer	1.22e-05	0.000758	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—HRAS—ovarian cancer	1.19e-05	0.00074	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—HRAS—ovarian cancer	1.16e-05	0.000727	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—YAP1—ovarian cancer	1.15e-05	0.000718	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—HRAS—ovarian cancer	1.14e-05	0.000714	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.14e-05	0.00071	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—HRAS—ovarian cancer	1.14e-05	0.000709	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—HRAS—ovarian cancer	1.12e-05	0.000697	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.11e-05	0.000691	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.11e-05	0.000691	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.11e-05	0.00069	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NME2—ovarian cancer	1.06e-05	0.000659	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYTB—ovarian cancer	1.03e-05	0.000643	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.01e-05	0.000629	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1e-05	0.000624	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—HRAS—ovarian cancer	9.76e-06	0.000609	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—FASN—ovarian cancer	9.38e-06	0.000585	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—SLC5A5—ovarian cancer	9.22e-06	0.000575	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—BRIP1—ovarian cancer	9.02e-06	0.000562	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PPP1CC—ovarian cancer	9.02e-06	0.000562	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—SLC2A1—ovarian cancer	8.91e-06	0.000556	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.72e-06	0.000544	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—YAP1—ovarian cancer	8.6e-06	0.000536	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP1B1—ovarian cancer	8.54e-06	0.000533	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.07e-06	0.000504	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PPP2R1A—ovarian cancer	7.57e-06	0.000472	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.54e-06	0.00047	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—YAP1—ovarian cancer	7.43e-06	0.000463	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.35e-06	0.000459	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ABCB1—ovarian cancer	7.03e-06	0.000439	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—FASN—ovarian cancer	7.01e-06	0.000437	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—TYMS—ovarian cancer	6.91e-06	0.000431	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—SLC5A5—ovarian cancer	6.89e-06	0.00043	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYTB—ovarian cancer	6.8e-06	0.000424	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—SLC2A1—ovarian cancer	6.66e-06	0.000415	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.57e-06	0.00041	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.46e-06	0.000403	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP1B1—ovarian cancer	6.38e-06	0.000398	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—FASN—ovarian cancer	6.06e-06	0.000378	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—YAP1—ovarian cancer	6.05e-06	0.000377	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.98e-06	0.000373	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—SLC5A5—ovarian cancer	5.96e-06	0.000372	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.95e-06	0.000371	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.95e-06	0.000371	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—SLC2A1—ovarian cancer	5.75e-06	0.000359	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	5.66e-06	0.000353	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.63e-06	0.000351	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CAV1—ovarian cancer	5.57e-06	0.000347	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP1B1—ovarian cancer	5.52e-06	0.000344	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.32e-06	0.000332	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.26e-06	0.000328	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ABCB1—ovarian cancer	5.26e-06	0.000328	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—TYMS—ovarian cancer	5.16e-06	0.000322	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CG—ovarian cancer	5.07e-06	0.000316	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—FASN—ovarian cancer	4.93e-06	0.000307	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	4.89e-06	0.000305	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.87e-06	0.000304	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.85e-06	0.000302	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.68e-06	0.000292	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.59e-06	0.000286	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ABCB1—ovarian cancer	4.54e-06	0.000283	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.49e-06	0.00028	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—TYMS—ovarian cancer	4.46e-06	0.000278	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CD—ovarian cancer	4.46e-06	0.000278	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CAV1—ovarian cancer	4.16e-06	0.000259	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—YAP1—ovarian cancer	3.99e-06	0.000249	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.98e-06	0.000248	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.96e-06	0.000247	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CB—ovarian cancer	3.88e-06	0.000242	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CG—ovarian cancer	3.79e-06	0.000236	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.7e-06	0.000231	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—TYMS—ovarian cancer	3.63e-06	0.000227	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CAV1—ovarian cancer	3.59e-06	0.000224	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.43e-06	0.000214	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PTEN—ovarian cancer	3.36e-06	0.000209	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CD—ovarian cancer	3.33e-06	0.000208	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.27e-06	0.000204	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—FASN—ovarian cancer	3.25e-06	0.000203	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.2e-06	0.000199	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.09e-06	0.000193	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.96e-06	0.000185	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CAV1—ovarian cancer	2.93e-06	0.000183	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.9e-06	0.000181	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.88e-06	0.00018	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.8e-06	0.000174	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.67e-06	0.000166	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.63e-06	0.000164	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.51e-06	0.000157	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTEN—ovarian cancer	2.51e-06	0.000156	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.44e-06	0.000152	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TYMS—ovarian cancer	2.39e-06	0.000149	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CA—ovarian cancer	2.37e-06	0.000148	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.34e-06	0.000146	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTEN—ovarian cancer	2.17e-06	0.000135	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.04e-06	0.000127	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—AKT1—ovarian cancer	1.93e-06	0.000121	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CAV1—ovarian cancer	1.93e-06	0.00012	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.77e-06	0.00011	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTEN—ovarian cancer	1.76e-06	0.00011	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.76e-06	0.00011	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.55e-06	9.64e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.53e-06	9.54e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—AKT1—ovarian cancer	1.45e-06	9.02e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.35e-06	8.4e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—AKT1—ovarian cancer	1.25e-06	7.79e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.24e-06	7.77e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTEN—ovarian cancer	1.16e-06	7.26e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—AKT1—ovarian cancer	1.02e-06	6.34e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.21e-07	5.12e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—AKT1—ovarian cancer	6.71e-07	4.18e-05	CbGpPWpGaD
